Clinical trials
Phase 1/2 Non-alcoholic Fatty Liver Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 2 |
| 89bio, Inc. | 1 |
| Adrian Vella | 1 |
| Corewell Health East | 1 |
| Elif Oral | 1 |
| Forma Therapeutics, Inc. | 1 |
| Joel Lavine | 1 |
| Massachusetts General Hospital | 1 |
| Nemours Children's Clinic | 1 |
| Northwell Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 14 |
| Fatty Liver | 7 |
| Obesity | 4 |
| Fibrosis | 3 |
| Liver Diseases | 2 |
| Cardiovascular Diseases | 1 |
| Hypertriglyceridemia | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Lipodystrophy, Familial Partial | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.